---
title: "Zepp Health Sets Third-Quarter 2026 Results Release"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305002523.md"
description: "Zepp Health will release its unaudited third-quarter 2026 financial results on November 22, 2026. An earnings conference call hosted by management will take place at 8:30 p.m. Eastern Time on the same day. A telephone replay of the call will be available one hour after the conclusion and remain accessible through November 29, 2026."
datetime: "2026-11-10T11:30:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305002523.md)
  - [en](https://longbridge.com/en/news/305002523.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305002523.md)
generator: "portal-rs"
---

# Zepp Health Sets Third-Quarter 2026 Results Release

-   Zepp Health will report unaudited third-quarter 2026 financial results on Nov. 22, 2026. \* Management will host an earnings conference call on Nov. 22, 2026, at 8:30 p.m. Eastern Time. \* A telephone replay will be available one hour following the call’s conclusion through Nov. 29, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zepp Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611100630PR\_NEWS\_USPR\_\_\_\_\_CN93644) on November 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ZEPP.US](https://longbridge.com/en/quote/ZEPP.US.md)

## Related News & Research

- [Zoomability Announces Availability of Q3 2026 Report](https://longbridge.com/en/news/306354193.md)
- [How Investors Are Reacting To On Holding (ONON) Strong Results Hold Guidance](https://longbridge.com/en/news/306367940.md)
- [EigenCloud (prev. EigenLayer): Unlocks 36.82 million EIGEN - Dec 2026](https://longbridge.com/en/news/306354415.md)
- [MOG.A: FY27 guidance targets 9% sales growth and a 14.2% adjusted segment margin](https://longbridge.com/en/news/306365896.md)
- [CAPR: FDA issued a CRL for Deramiocel, citing insufficient evidence of effectiveness](https://longbridge.com/en/news/306366333.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**